FingerMotion Inc. reported total annual revenue of $16.68 million for the 2021 financial year ended February 28, 2021 This FYE 2021 results represented an 82% growth from the FYE 2020 results The company also posted $2.11 million in positive shareholders’ equity The growth was attributed to an increase in subscriber numbers, resource optimization, and the […]

Date: June 15-17, 2021 Virtual Event Event Highlights The conference aims to ensure compliant pre-market and post-market operations The event will feature case studies, panel discussions, and presentations by 15+ industry professionals holding senior positions at various pharmaceutical and biotechnology companies Attendees should expect to get their unique needs addressed as the program includes Q&A […]

Health and wellness CBD-based probiotics distributor HempFusion Wellness, Inc. recently announced an agreement to acquire CBD brand pioneer Apothecanna’s holding company The deal will give HempFusion an additional 1,800 retail outlets for its brand, notably in CVS stores, to supplement the 4,000 retail locations HempFusion already uses in all 50 states Apothecanna’s sales revenues during […]

Feasibility study is designed to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics Cybin, Kernel working together to leverage proprietary Kernel Flow device for psychedelic-based studies and clinical trials Ketamine is a dissociative injected anesthetic that blocks sensory perception Cybin (NEO: CYBN) (OTCQB: CLXPF) has announced a key step forward in its focus on progressing […]

Further refinement of if the i/Blue Imaging System will incorporate changes intended to meet critical verification requirements established through benchmark testing of competitive systems as well as feedback from preliminary meetings with the FDA Bladder cancer is anticipated to cause over 1,000,000 physician consultations per year, resulting in $4 billion in total costs for bladder […]

Tryp Therapeutics’ Chairman and CEO Greg McKee will present at the virtual Psychedelics in Psychiatry and Beyond Conference planned for Thursday, June 17, 2021 As part of his presentation, McKee will discuss Tryp’s business and its pipeline, which includes its proprietary psilocybin-centered drug development program Tryp will present alongside other pharmaceutical companies leading research in […]

New report cites new management, very good customer ratings and record revenue in initiating CHAL coverage Chalice Brands acquisition of Homegrown Oregon also noted CHAL’s consistent increase in financial numbers key to BUY rating as well A recent Fundamental Research Corp. report has initiated coverage of Chalice Brands (CSE: CHAL) (OTCQB: CHALF) with a BUY […]

Americans pay more for prescription drugs than any other nation in the world; prices keep increasing Patients pay about 14% of prescription drug costs out of pockets; around 20% report not being able to complete a prescribed course of medicine due to costs UME’s committed to providing consumers better access to the healthcare they need; […]

Most extensive research to date reports significant neurological problems in patients who suffered from so-called long-haul COVID-19 Neurological issues range from mild to more severe such as cognitive impairment, which affects around 20% of these patients BRSF appears poised to be part of the solution as long-haulers need monitoring so that doctors can assess if […]

HempFusion Wellness Inc. offers a full line of CBD products for consumers and medical professionals, via subsidiaries Probulin Probiotics, HF Labs, and Biome Research Probulin finished 2020 as one of the fastest growing probiotic brand in the United States according to Spins Data Brightfield Group named HempFusion the #2 most recognized CBD brand in America […]